CrystalGenomics, Inc. - Product Pipeline Review - 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 37
Inquire Before Buying

CrystalGenomics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, ‘CrystalGenomics, Inc. - Product Pipeline Review, 2016', provides an overview of the CrystalGenomics, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by CrystalGenomics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of CrystalGenomics, Inc.

- The report provides overview of CrystalGenomics, Inc. including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses CrystalGenomics, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features CrystalGenomics, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate CrystalGenomics, Inc.'s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for CrystalGenomics, Inc.

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding CrystalGenomics, Inc.'s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

CrystalGenomics, Inc. - Product Pipeline Review - 2016

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
CrystalGenomics, Inc. Snapshot 5
CrystalGenomics, Inc. Overview 5
Key Information 5
Key Facts 5
CrystalGenomics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
CrystalGenomics, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
CrystalGenomics, Inc. - Pipeline Products Glance 12
CrystalGenomics, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
CrystalGenomics, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
CrystalGenomics, Inc. - Drug Profiles 16
CG-400549 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CG-200745 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CG-026806 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CG-036806 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
polmacoxib 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CG-0009 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Target Metalloproteinases for Undisclosed Indication 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule to Target Nuclear Hormone Receptors for Undisclosed Indication 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Target Phosphodiesterases for Undisclosed Indication 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CrystalGenomics, Inc. - Pipeline Analysis 26
CrystalGenomics, Inc. - Pipeline Products by Target 26
CrystalGenomics, Inc. - Pipeline Products by Route of Administration 28
CrystalGenomics, Inc. - Pipeline Products by Molecule Type 29
CrystalGenomics, Inc. - Pipeline Products by Mechanism of Action 30
CrystalGenomics, Inc. - Recent Pipeline Updates 31
CrystalGenomics, Inc. - Dormant Projects 34
CrystalGenomics, Inc. - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 36
Disclaimer 37

List of Tables
CrystalGenomics, Inc., Key Information 5
CrystalGenomics, Inc., Key Facts 5
CrystalGenomics, Inc. - Pipeline by Indication, 2016 7
CrystalGenomics, Inc. - Pipeline by Stage of Development, 2016 8
CrystalGenomics, Inc. - Monotherapy Products in Pipeline, 2016 9
CrystalGenomics, Inc. - Partnered Products in Pipeline, 2016 10
CrystalGenomics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 11
CrystalGenomics, Inc. - Phase II, 2016 12
CrystalGenomics, Inc. - Phase I, 2016 13
CrystalGenomics, Inc. - Preclinical, 2016 14
CrystalGenomics, Inc. - Discovery, 2016 15
CrystalGenomics, Inc. - Pipeline by Target, 2016 27
CrystalGenomics, Inc. - Pipeline by Route of Administration, 2016 28
CrystalGenomics, Inc. - Pipeline by Molecule Type, 2016 29
CrystalGenomics, Inc. - Pipeline Products by Mechanism of Action, 2016 30
CrystalGenomics, Inc. - Recent Pipeline Updates, 2016 31
CrystalGenomics, Inc. - Dormant Developmental Projects,2016 34
CrystalGenomics, Inc., Subsidiaries 35

List of Figures
CrystalGenomics, Inc. - Pipeline by Top 10 Indication, 2016 7
CrystalGenomics, Inc. - Pipeline by Stage of Development, 2016 8
CrystalGenomics, Inc. - Monotherapy Products in Pipeline, 2016 9
CrystalGenomics, Inc. - Pipeline by Target, 2016 26
CrystalGenomics, Inc. - Pipeline by Route of Administration, 2016 28
CrystalGenomics, Inc. - Pipeline by Molecule Type, 2016 29
CrystalGenomics, Inc. - Pipeline Products by Mechanism of Action, 2016 30
  • China Bio-pharma Market Research Report 2017
    Published: 11-Dec-2017        Price: US 3400 Onwards        Pages: 109
    The global Bio-pharma market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Bio-pharma development status and future trend in China, focuses on top players in China, also splits Bio-pharma by type and b......
  • Global and Regional Bio-pharma Market Research Report 2017
    Published: 03-Dec-2017        Price: US 3500 Onwards        Pages: 182
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Monoclonal Antibodies - Recombinant Proteins - Granulocyte-Colony Stimulating Factor (G-CSF) - Interferons - Recombinant Human Insulin - Erythropoietin - Vaccines - Growth Hormones - Purified Proteins - Others ......
  • Global Bio-pharma Market Professional Survey Report 2017
    Published: 30-Nov-2017        Price: US 3500 Onwards        Pages: 110
    This report studies Bio-pharma in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, A......
  • Global Bio-pharma Market Data Survey Report 2025
    Published: 10-Nov-2017        Price: US 1500 Onwards        Pages: 116
    Summary The global Bio-pharma market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Average market price by SUK Major applications Key manufacturers are included based on manufacturing......
  • Global Bio-pharma Market Research Report 2011-2023
    Published: 09-Nov-2017        Price: US 3610 Onwards        Pages: 116
    Summary The global Bio-pharma market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned as follows:......
  • Global Biopharmaceuticals Market Professional Survey Report 2017
    Published: 25-Oct-2017        Price: US 3500 Onwards        Pages: 103
    This report studies Biopharmaceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Roche - Amgen - AbbVie - Sanofi-Aventis - Johnson & Johnso......
  • United States Biopharmaceuticals Market Report 2017
    Published: 03-Oct-2017        Price: US 3800 Onwards        Pages: 97
    In this report, the United States Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate ......
  • Global Biopharmaceuticals Sales Market Report 2017
    Published: 28-Sep-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the global Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Biopharmaceuticals for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • Global Biopharmaceuticals Market Research Report 2017
    Published: 18-Sep-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biopharmaceuticals in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs